You have selected a link to a third-party website or a link that will direct you to an EMD Serono, Inc. page that may contain Marketed and/or Investigational product information.
For third-party websites, this link is provided solely as a convenience to you and not as an endorsement by EMD Serono, Inc. of such third-party website. EMD Serono, Inc. is not responsible for and does not make any representations regarding the accuracy of material on such third-party site.
Are you a US-based medical or scientific professional?
THANK YOU FOR VISITING!
The information on this website is intended for medical and scientific professionals based in the U.S. Below are some additional resources that may be useful to you.
The list above may contain links to third party web sites. These are provided solely as a convenience to you and not as an endorsement by EMD Serono, Inc. of the content on such third-party web sites. EMD Serono, Inc. is not responsible for the content of linked third-party sites and does not make any representations regarding the content or accuracy of materials on such third-party sites. If you decide to access linked third-party sites, you do so at your own risk.
• M9241 is an investigational cancer immuno-cytokine designed for targeted delivery of IL-12 to the tumor microenvironment by targeting regions of tumor necrosis and apoptosis using a naked DNA-detecting antibody